These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3751759)

  • 1. [Investigation of the vitreo-retino-ciliary barrier by vitreous fluorophotometry. 5. Alteration of the inward permeability of the blood-retinal barrier and the diffusion coefficient of fluorescein in the vitreous with aging in normal subjects].
    Yoshida A; Murakami K; Kojima M
    Nippon Ganka Gakkai Zasshi; 1986 Apr; 90(4):589-94. PubMed ID: 3751759
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimation of the permeability of the blood-retinal barrier in normal individuals.
    Oguro Y; Tsukahara Y; Saito I; Kondo T
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):969-76. PubMed ID: 4008211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interpretation of vitreous fluorophotometry.
    Zeimer RC; Blair NP; Cunha-Vaz JG
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1374-81. PubMed ID: 6618797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to fluorescein and protein movement.
    Marmor MF
    Jpn J Ophthalmol; 1985; 29(2):131-8. PubMed ID: 2413231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport of fluorescein in the ocular posterior segment in retinitis pigmentosa.
    Mallick KS; Zeimer RC; Fishman GA; Blair NP; Anderson RJ
    Arch Ophthalmol; 1984 May; 102(5):691-6. PubMed ID: 6721754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of the vitreo-retino-ciliary barrier by vitreous fluorophotometry. I. Evaluation of age differences in normal adults].
    Yoshida A; Furukawa H; Murakami K; Takahashi M; Hosaka A
    Nippon Ganka Gakkai Zasshi; 1985 May; 89(5):683-7. PubMed ID: 4025073
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of fluorescein in the vitreous.
    Palestine AG; Brubaker RF
    Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):542-9. PubMed ID: 7287343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo.
    Engler CB; Sander B; Larsen M; Dalgaard P; Lund-Andersen H
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):655-62. PubMed ID: 7747570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of blood-retinal barrier permeability: a reproducibility study in normal eyes.
    Chahal PS; Chowienczyk PJ; Kohner EM
    Invest Ophthalmol Vis Sci; 1985 Jul; 26(7):977-82. PubMed ID: 4008212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outward transport of fluorescein from the vitreous in normal human subjects.
    Blair NP; Zeimer RC; Rusin M; Cunha-Vaz JG
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):266. PubMed ID: 3979854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of permeability in blood-retinal barrier.
    Kojima M; Yoshida A; Ishiko S; Tanaka K
    Hokkaido Igaku Zasshi; 1990 Jul; 65(4):419-27. PubMed ID: 2227794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous fluorophotometry: mathematical analysis of the effect of peripheral leakage on axial scans.
    Dalgaard P; Barker VA; Lund-Andersen H
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1522-6. PubMed ID: 2744996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of the blood-retinal barrier in experimental diabetes. Vitreous fluorophotometry using carboxyfluorescein and fluorescein.
    Blair NP; Jones CW; Rusin MM
    Arch Ophthalmol; 1984 Dec; 102(12):1810-4. PubMed ID: 6508620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outward transport of fluorescein from the vitreous in normal human subjects.
    Blair NP; Zeimer RC; Rusin MM; Cunha-Vaz JG
    Arch Ophthalmol; 1983 Jul; 101(7):1117-21. PubMed ID: 6870634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the technique of vitreous fluorophotometry.
    Zeimer RC; Cunha-Vaz JG; Johnson ME
    Invest Ophthalmol Vis Sci; 1982 May; 22(5):668-74. PubMed ID: 7076410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of fluorescein glucuronide and its metabolism in vitreous fluorophotometry.
    Plehwe WE; Chahal PS; Fallon TJ; Cunningham JR; Neal MJ; Kohner EM
    Exp Eye Res; 1987 Feb; 44(2):209-15. PubMed ID: 3582508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of fluorescein to vitreous in vitro.
    Knudsen LL
    Acta Ophthalmol (Copenh); 1987 Jun; 65(3):352-7. PubMed ID: 3618161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-retinal barrier permeability to carboxyfluorescein and fluorescein in monkeys.
    Blair NP; Rusin MM
    Graefes Arch Clin Exp Ophthalmol; 1986; 224(5):419-22. PubMed ID: 3093315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine.
    Nuzzi G; Venturini I; De Gregorio M; Arsenio L; Maraini G
    Acta Ophthalmol Scand; 1997 Feb; 75(1):41-3. PubMed ID: 9088399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oscillatory potentials and permeability of the blood-retinal barrier in noninsulin-dependent diabetic patients without retinopathy.
    Yoshida A; Kojima M; Ogasawara H; Ishiko S
    Ophthalmology; 1991 Aug; 98(8):1266-71. PubMed ID: 1923365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.